Related Concept Videos
Blinding
Randomized Experiments
Simple randomization
Simple...
Censoring Survival Data
Assumptions of Survival Analysis
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Regression Toward the Mean
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel.
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.
Monitoring overall survival in pivotal trials in indolent cancers.
Aspirin in primary prevention: Undue reliance on an uninformative trial led to misinformed clinical guidelines.
Leveraging external controls in clinical trials: estimands, estimation, assumptions.
Special issue of nonclinical statistics in regulatory applications guest editors' notes.
Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.
Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.
Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.
Related Experiment Video
Updated: Jun 15, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Missing inaction: preventing missing outcome data in randomized clinical trials.
1Statistics Collaborative, Washington, DC, USA.
Minimizing missing data in clinical trials is crucial for accurate results. Strategies include investigator training and clear communication about trial completion versus stopping medication.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Data Management in Research
Background:
- Numerous statistical methods exist for handling missing data in randomized clinical trials.
- High proportions of missing outcome data can lead to inaccurate effect size estimations.
- Ongoing statistical research addresses missing data challenges.
Purpose of the Study:
- To advocate for minimizing missing data in randomized clinical trials.
- To propose practical strategies for reducing missing data proportions.
- To enhance the integrity of clinical trial results.
Main Methods:
- Review of existing statistical approaches for missing data.
- Proposal of investigator and participant training initiatives.
- Development of specific language for trial documentation (informed consent, protocols, case report forms).
Main Results:
- Current methods may yield inaccurate estimates when missing data is substantial.
- Training can improve participant and investigator adherence.
- Clear documentation distinguishes between medication cessation and trial withdrawal.
Conclusions:
- Trialists must prioritize minimizing missing data to ensure reliable study outcomes.
- Proactive strategies, including enhanced communication and documentation, are essential.
- Reducing missing data improves the validity and accuracy of clinical trial evidence.